Federal Circuit affirms Merck ‘unclean hands’ verdict

26-04-2018

Federal Circuit affirms Merck ‘unclean hands’ verdict

inakiantonana / iStockphoto.com

The US Court of Appeals for the Federal Circuit has affirmed a finding that pharmaceutical company Merck had engaged in misconduct and was not allowed to bring an action against Gilead.


Merck, Gilead, hepatitis C, patent infringement, Harvoni, Sovaldi, US Court of Appeals for the Federal Circuit

LSIPR